Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1176 |
---|---|
Product Name | Anti-Human CD257 Recombinant Antibody(Belimumab) |
Molecular Name | Belimumab |
Alias | Anti-CD257 Recombinant Antibody, Research Grade Belimumab |
CAS Number | 356547-88-1 |
Molecular Weight | 147 kDa |
Target | CD257[Homo sapiens] |
Isotype | IgG1 Lambda |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | FCM, IP, ELISA, Neut, FuncS, IF |
Buffer | PBS, pH7.5 |
Background | Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). It is approved in the United States, Canada, and the European Union to treat systemic lupus erythematosus (SLE). |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |